KRISTEN TEIXEIRA: Open Payments
NPI 1760016638 · HAMILTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,086 in 189 payments from 18 companies in 2025. Trend: 2023 $3,441 · 2024 $5,176 · 2025 $4,086
Food & beverage: $2,976Consulting: $1,000Education: $110
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $1,016 |
| Janssen Biotech, Inc. | 22 | $468 |
| Incyte Corporation | 11 | $466 |
| ABBVIE INC. | 40 | $423 |
| Novartis Pharmaceuticals Corporation | 14 | $318 |
| Lilly USA, LLC | 20 | $204 |
| PFIZER INC. | 11 | $195 |
| Galderma Laboratories, L.P. | 17 | $192 |
| Amgen Inc. | 10 | $181 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $162 |
Products named: TREMFYA, Opzelura, COSENTYX, SKYRIZI, CIBINQO, RINVOQ, OTEZLA, EBGLYSS.
Industry payments across NJ — which companies pay providers there.
